Cargando…
A New NT4 Peptide-Based Drug Delivery System for Cancer Treatment
The development of selective tumor targeting agents to deliver multiple units of chemotherapy drugs to cancer tissue would improve treatment efficacy and greatly advance progress in cancer therapy. Here we report a new drug delivery system based on a tetrabranched peptide known as NT4, which is a pr...
Autores principales: | Brunetti, Jlenia, Piantini, Sara, Fragai, Marco, Scali, Silvia, Cipriani, Giulia, Depau, Lorenzo, Pini, Alessandro, Falciani, Chiara, Menichetti, Stefano, Bracci, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179244/ https://www.ncbi.nlm.nih.gov/pubmed/32121130 http://dx.doi.org/10.3390/molecules25051088 |
Ejemplares similares
-
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells
por: Bracci, Luisa, et al.
Publicado: (2018) -
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug
por: Brunetti, Jlenia, et al.
Publicado: (2015) -
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate
por: Depau, Lorenzo, et al.
Publicado: (2017) -
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging
por: Brunetti, Jlenia, et al.
Publicado: (2018) -
A Novel Phage-Library-Selected Peptide Inhibits Human TNF-α Binding to Its Receptors
por: Brunetti, Jlenia, et al.
Publicado: (2014)